P Ia Grigor'ev

Author PubWeight™ 0.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Effects of probiotic bifiform on efficacy of Helicobacter pylori infection treatment]. Ter Arkh 2006 0.76
2 [Differential diagnosis of thyroid cancer]. Klin Med (Mosk) 1972 0.75
3 [Treatment of cholelithiasis]. Sov Med 1988 0.75
4 [Determination of the functional state of the thyroid gland by use of the DSU-61 unit in a locality with endemic goiter]. Probl Endokrinol Gormonoter 1967 0.75
5 [Comparative clinico-morphological characteristics of endemic goiter in Amur district]. Vestn Khir Im I I Grek 1973 0.75
6 [Comparative evaluation of the efficacy of monotherapy with cimetidine and combined treatment of the recurrent duodenal ulcer]. Ter Arkh 1983 0.75
7 [Constipation: from the symptom to the diagnosis and adequate treatment]. Ter Arkh 1996 0.75
8 [Certain characteristics of the condition of the gastroduodenal region in patients with chronic hepatitis (according to endoscopic and intragastric pH-metric data)]. Ter Arkh 1976 0.75
9 [Differential use of immunostimulants with chronic pneumonia patients]. Ter Arkh 1983 0.75
10 [Hepatic encephalopathy: its etiology, pathogenesis, clinical diagnostic criteria and treatment principles]. Ter Arkh 1990 0.75
11 [Drug therapy and therapeutic tactics in gastroduodenal ulcer]. Ter Arkh 1988 0.75
12 [Causes of postoperative recurrence and therapy of peptic ulcer]. Klin Med (Mosk) 1990 0.75
13 [Disorder in mechanisms of bile formation and methods of their correction]. Eksp Klin Gastroenterol 2003 0.75
14 [VIII Congress of Russian Gastroenterological Scientific Society. XXXIV Session of the Central Research Institute of Gastroenterology (4-7 March, 2008, Moscow). Standards "Diagnosis and therapy of acid-dependent diseases including Helicobacter pylori-associated diseases" (Third Moscow Agreement, 04.02.05 with supplements adopted on 06.03.08 by VIII Congress of Russian Gastroenterological Scientific Society)]. Eksp Klin Gastroenterol 2008 0.75
15 [Characteristics of respiration in thyrotoxic goiter]. Vestn Khir Im I I Grek 1966 0.75
16 [The comparative efficacy of ranitidine and famotidine in treating exacerbations of duodenal peptic ulcer]. Klin Med (Mosk) 1993 0.75
17 [Morpho-functional characteristics of peptic ulcer at the slope of clinical remission]. Vrach Delo 1977 0.75
18 [Principles of classification of peptic ulcer]. Vrach Delo 1977 0.75
19 [Immunity indices during the use of prodigiozan in treating acute pneumonias]. Sov Med 1980 0.75
20 [Cytoprotectors in stomach diseases therapy. Best practice in the drug selection]. Eksp Klin Gastroenterol 2006 0.75
21 [Effectiveness of cimetidine and ranitidine in peptic ulcer]. Sov Med 1986 0.75
22 [Current views on the etiology and pathogenesis of peptic ulcer]. Vestn Akad Med Nauk SSSR 1990 0.75
23 [Reflux esophagitis in duodenal ulcer and therapeutic problems]. Ter Arkh 1982 0.75
24 [Campylobacter pyloridis in chronic gastritis and peptic ulcer]. Sov Med 1988 0.75
25 [Value of scanning in determination of the functional capacity of thyroid gland tissue]. Vestn Khir Im I I Grek 1969 0.75
26 [Current concepts of chronic gastritis (a review of the literature)]. Vrach Delo 1988 0.75
27 [Thirty years of practice in treatment of ulcer]. Klin Med (Mosk) 1999 0.75
28 [A course and outcome of chronic hepatitis with the presence of serum markers of replication phase of hepatitis B virus]. Sov Med 1991 0.75
29 [Helicobacter pylori infection in patients with liver cirrhosis: diagnostics and problems of therapy]. Eksp Klin Gastroenterol 2006 0.75
30 [Contemporary trends in pharmacotherapy of intestinal tract diseases]. Klin Med (Mosk) 1999 0.75
31 [Comparative evaluation of the efficacy of complex anti-ulcer therapy and monotherapy]. Sov Med 1984 0.75
32 [The drug treatment of gastric and duodenal peptic ulcer]. Ter Arkh 1995 0.75
33 [The electrocardiogram in thyreotoxic heart]. Sov Med 1966 0.75
34 [Pathogenesis of bronchial asthma]. Vrach Delo 1976 0.75
35 [Chronic gastritis: current theories on its pathogenesis, clinical course and treatment]. Ter Arkh 1989 0.75
36 [Practical recommendations regarding the treatment and prevention of peptic ulcer]. Sov Med 1991 0.75
37 [The teaching of oncology]. Vopr Onkol 1971 0.75
38 [Experience in increasing the effectiveness of patient rehabilitation in peptic ulcer]. Klin Med (Mosk) 1984 0.75
39 [Characteristics of the endoscopic diagnosis of peptic ulcer and chronic gastritis associated with Campylobacter pylori]. Ter Arkh 1989 0.75
40 [Treatment of peptic ulcer with ulcosilvanil]. Sov Med 1984 0.75
41 [Complex conservative treatment of thyreotoxic goiter]. Sov Med 1969 0.75
42 [Gastroduodenal diseases associated with helicobacter pylori]. Klin Med (Mosk) 1998 0.75
43 [Chronic pancreatitis, clinical manifestations and diagnostics]. Eksp Klin Gastroenterol 2007 0.75
44 [Relapse and remission in peptic ulcer]. Klin Med (Mosk) 1977 0.75
45 [The rational use of De-Nol in the treatment of peptic ulcer and chronic active gastroduodenitis associated with Helicobacter pylori]. Ter Arkh 1992 0.75
46 [Methods to optimize the management of Helicobacter pylori infection. The comparative efficacy of the triple and quadruple therapy used as a first line therapy]. Eksp Klin Gastroenterol 2004 0.75
47 [Chronic pancreatitis: current theories on its etiology, pathogenesis, clinical course and drug treatment (review of foreign literature)]. Klin Med (Mosk) 1988 0.75
48 [Work experience of personnel of the institute for aiding practical public health]. Zdravookhr Ross Fed 1967 0.75
49 [Pathophysiologic bases of the pharmacotherapy of peptic ulcer]. Klin Med (Mosk) 1988 0.75
50 [Peptic ulcer associated with reflux esophagitis and its treatment]. Sov Med 1981 0.75
51 [Experience with transendoscopic ultrasonic therapy of stomach ulcer]. Klin Med (Mosk) 1990 0.75
52 [Ambulatory care of patients with a history of acute pneumonia]. Vrach Delo 1981 0.75
53 [Treatment of peptic ulcer with gastrozepin]. Sov Med 1984 0.75
54 [Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems]. Klin Med (Mosk) 1991 0.75
55 [New aspects in the etiology and pathogenesis of chronic gastritis and peptic ulcer]. Ter Arkh 1988 0.75
56 [Pharmacotherapy of stomach and duodenal ulcers]. Sov Med 1986 0.75
57 [The pathogenetic bases of alimentary obesity]. Ter Arkh 1989 0.75
58 [The pathological consequences of Helicobacter infection in man and the new developments in treating peptic ulcer (based on the materials from the European Gastroenterology Week, 21-26 October 1991, Amsterdam]. Ter Arkh 1993 0.75
59 [Experience with endoscopy]. Vrach Delo 1978 0.75
60 [Clinical aspects and diagnosis of chronic viral hepatitis B]. Klin Med (Mosk) 1984 0.75
61 [The drug prophylaxis of peptic ulcer exacerbations]. Ter Arkh 1995 0.75
62 [Use of sucralfate in the treatment of peptic ulcer]. Klin Med (Mosk) 1989 0.75
63 [Diagnosis and treatment of chronic hepatitis and liver cirrhosis]. Sov Med 1985 0.75
64 [A method of determining Campylobacter pylori in the gastric mucosa in peptic ulcer and chronic gastritis]. Lab Delo 1989 0.75
65 [Phases of peptic ulcer]. Klin Med (Mosk) 1989 0.75
66 [Clinical assessment of the changes in the ventricular complex of the ECG in thyreotoxic goiter]. Ter Arkh 1966 0.75
67 [Gastrotsepin in the therapy and prevention of peptic ulcer exacerbations associated with Helicobacter pylori bacteriosis]. Klin Med (Mosk) 1995 0.75
68 [Staged treatment of peptic ulcer recurrence]. Klin Med (Mosk) 1981 0.75
69 [Famotidine--a new histamine H2 receptor blockader]. Klin Med (Mosk) 1991 0.75
70 [The role of the polyclinic in raising the efficacy of rehabilitation with peptic ulcer patients]. Ter Arkh 1992 0.75
71 [Characteristics of the blood serum protein composition in patients with toxic goiter]. Probl Endokrinol Gormonoter 1966 0.75
72 [Clinical and morphologic comparisons in toxic goiter]. Arkh Patol 1967 0.75
73 [Osmotic resistance of leukocytes and leukolysis in lymphocytic leukemia]. Ter Arkh 1976 0.75
74 [The effectiveness of 7-day combined Helicobacter eradication therapy in patients with peptic ulcer and chronic gastritis]. Klin Med (Mosk) 2001 0.75
75 [Litholytic therapy of gallstones]. Voen Med Zh 1987 0.75
76 [Evaluation of long-term conservative treatment of ulcer disease]. Klin Med (Mosk) 1975 0.75
77 [Treatment of peptic ulcer]. Sov Med 1983 0.75
78 [Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer]. Sov Med 1991 0.75
79 [Endoscopic characteristics of gastroduodenal zone in patients with ulcer disease]. Sov Med 1976 0.75
80 [Etiologic and pathologic approaches to pharmacotherapy of peptic ulcer]. Ter Arkh 1991 0.75
81 [Local factors in the pathogenesis of peptic ulcer]. Klin Med (Mosk) 1988 0.75